Notes
$AXP F/Y GUIDANCE
🔸 Sees revenue +8% to +10%
🔸 Sees EPS $15 to $15.50, EST $15.24
RESULTS: Q4
🔸 EPS $3.04 vs. $2.62 y/y, EST $3.04
🔸 Revenue $17.18B, +8.7% y/y, EST $17.17B
🔸 Provision for credit losses $1.3B, -9.5% y/y
🔸 Billed business $408.4B, +7.5% y/y, EST $402.49B
🔸 Total expenses $13.1B, EST $12.88B
#Downgrades - Oct 08, 2024
$ALB: CFRA Downgrades to Hold from Buy - PT $99
$AXP: HSBC Downgrades to Hold from Buy
$AXP: BTIG Downgrades to Sell from Neutral - PT $230
$BUD: TD Cowen Downgrades to Hold from Buy - PT $68
$CME: Redburn-Atlantic Downgrades to Neutral from Buy - PT $244
$FYBR: TD Cowen Downgrades to Hold from Buy - PT $38.50 (from $39)
$MSFT: Oppenheimer Downgrades to Perform from Outperform
$OMF: Barclays Downgrades to Equalweight from Overweight - PT $46 (from $52)
$OTIS: Wolfe Research Downgrades to Peerperform from Outperform
$QCOM: KeyBanc Downgrades to Sector Weight from Overweight
$STZ: TD Cowen Downgrades to Hold from Buy - PT $270 (from $300)
$SYNA: KeyBanc Downgrades to Sector Weight from Overweight